Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-(carboxymethylthio)tetradecane

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-(carboxymethylthio)tetradecane in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(1-(carboxymethylthio)tetradecane)
Trials
(1-(carboxymethylthio)tetradecane)
Recent Studies (post-2010) (1-(carboxymethylthio)tetradecane)
9,156187552143532

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berge, RK; Felberg, HS; Johansen, B; Jørgensen, KM; Laegreid, A1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-(carboxymethylthio)tetradecane

ArticleYear
Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2.
    Archives of dermatological research, 2010, Volume: 302, Issue:3

    Topics: Arachidonic Acid; Calcium; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Group IV Phospholipases A2; Group VI Phospholipases A2; Humans; Inflammation; Inflammation Mediators; Ionophores; Isoenzymes; Keratinocytes; Organometallic Compounds; Phospholipase A2 Inhibitors; Phospholipases A2; Phospholipases A2, Secretory; Platelet Activating Factor; Signal Transduction; Sulfides

2010